VT
RMD icon

Vise Technologies’s ResMed RMD Stock Holding History

Vise Technologies’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$571K Buy
2,929
+65
+2% +$13.5K 0.01% 1083
2026
Q1 		$690K Hold
2,864
– – 0.01% 720
2025
Q4 		$690K Buy
2,864
+1,012
+55% +$259K 0.01% 725
2025
Q3 		$507K Sell
1,852
-290
-14% -$79.2K 0.02% 666
2025
Q2 		$553K Buy
+2,142
New +$511K 0.02% 603
2024
Q4 		$267K Buy
+1,170
New +$282K 0.02% 644

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Vise Technologies's RMD Position: Q2 2026 in Review

Vise Technologies increased its ResMed (RMD) stake by 2.3% in Q2 2026, buying an estimated $13.5K and bringing the position to 2,929 shares worth $571K. The position accounts for 0.01% of the portfolio, ranked #1083.

Vise Technologies first reported a position in RMD in Q4 2024 and has held it in 6 quarters since. The position peaked at $690K in Q1 2026. 891 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Vise Technologies held 2,929 shares of ResMed worth $571K as of Q2 2026.
  • Vise Technologies bought 65 ResMed shares in Q2 2026, an estimated $13.5K.
  • ResMed made up 0.01% of Vise Technologies's portfolio in Q2 2026, its #1083 holding.
  • Vise Technologies first reported a position in ResMed in Q4 2024 and has held it in 6 quarters since.
  • Vise Technologies's ResMed position peaked at $690K in Q1 2026.
  • 891 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Vise Technologies's 13F filing for Q2 2026, filed 11 Aug 2026.